Brenner West Capital Advisors’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
Brenner West Capital Advisors's AGN Position: Q1 2017 in Review
Brenner West Capital Advisors sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 172,229 shares — an estimated $36.2M sold.
Brenner West Capital Advisors first reported a position in AGN in Q4 2015 and held it in 5 quarters. The position peaked at $90.6M in Q1 2016. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.
- Brenner West Capital Advisors reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
- Brenner West Capital Advisors sold 172,229 Allergan plc shares in Q1 2017, an estimated $36.2M.
- Brenner West Capital Advisors first reported a position in Allergan plc in Q4 2015 and held it in 5 quarters.
- Brenner West Capital Advisors's Allergan plc position peaked at $90.6M in Q1 2016.
- 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.
Based on Brenner West Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.